YUBO INTERNATIONAL BIOTECH LIMITED: 10-K filed 2014-06-06
What YUBO INTERNATIONAL BIOTECH LIMITED reported in its annual report filed 2014-06-06 (fiscal FY 2014): 14 published measures, 29 facts as tagged in accession 0001193805-14-001196.
This filing
- Form
- 10-K (annual report)
- Filed
- 2014-06-06
- Fiscal period
- fiscal FY 2014
- Accession
- 0001193805-14-001196 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All YUBO INTERNATIONAL BIOTECH LIMITED filings.
Reported measures
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-02-28 | -1,012,000 | USD | |
| At 2013-02-28 | -906,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-02-28 | 8,000 | USD | |
| At 2013-02-28 | 12,000 | USD | |
| At 2012-02-29 | 7,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-03-01 to 2014-02-28 | -106,000 | USD | 365 |
| 2012-03-01 to 2013-02-28 | -103,000 | USD | 365 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-03-01 to 2014-02-28 | -46,000 | USD | 365 |
| 2012-03-01 to 2013-02-28 | -38,000 | USD | 365 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-02-28 | -28,193,000 | USD | |
| At 2013-02-28 | -28,087,000 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-03-01 to 2014-02-28 | -55,000 | USD | 365 |
| 2012-03-01 to 2013-02-28 | -60,000 | USD | 365 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-02-28 | 11,000 | USD | |
| At 2013-02-28 | 15,000 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-03-01 to 2014-02-28 | 51,000 | USD | 365 |
| 2012-03-01 to 2013-02-28 | 43,000 | USD | 365 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-02-28 | 1,023,000 | USD | |
| At 2013-02-28 | 921,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-02-28 | 422,000 | USD | |
| At 2013-02-28 | 412,000 | USD |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-03-01 to 2014-02-28 | 55,000 | USD | 365 |
| 2012-03-01 to 2013-02-28 | 60,000 | USD | 365 |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-02-28 | 27,180,000 | USD | |
| At 2013-02-28 | 27,180,000 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-02-28 | 33,000 | USD | |
| At 2013-02-28 | 33,000 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-03-01 to 2014-02-28 | -106,000 | USD | 365 |
| 2012-03-01 to 2013-02-28 | -103,000 | USD | 365 |
Inspect the source
- Entity
- YUBO INTERNATIONAL BIOTECH LIMITED / CIK 0000895464
- Captured
- 2026-09-19T11:15:15.244Z
- SEC response SHA-256
c92a7fe28254e6bffc6926a6f7f269ff5ed2714bd234e3d50d981999866a6ed2
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000895464.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))